Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
iSpecimen Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Deficiency
- minimum bid price
- Rules
- 5550(a)(2)
Exact text from the filing
minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for the prior 30 consecutive business days. On May 12, 2026
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
iSpecimen Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
- Exchange
- nasdaq
- Notice
- compliance regained
- Deficiency
- minimum bid price
- Rules
- 5550(a)(2)
Exact text from the filing
May 12, 2026, the Company received a letter from Nasdaq (the “Compliance Letter”) notifying the Company that the Staff has determined that for the last 10 consecutive business days, from April 28, 2026 to May 11, 2026, t
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
iSpecimen Inc. entered into Securities Purchase Agreement with certain accredited investors valued at aggregate gross proceeds of approximately $2.5 million (effective 2026-05-08).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors
- Value
- aggregate gross proceeds of approximately $2.5 million
- Effective
- 2026-05-08
Exact text from the filing
On May 8, 2026, iSpecimen Inc., a Delaware corporation (Nasdaq: ISPC) (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell 488,281 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock” or “Shares”), at a purchase price of $5.12 per Share.
View on SEC.gov